SCHEMBL24319374

SCHEMBL24319374

CN1CCC(CN2CC3(CCN(C)C3)C2)CC1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NCF1 P14598 1/20 0.39
OPRM1 P35372 1/20 0.33
OPRL1 P41146 1/20 0.33
CACNA2D1 P54289 1/20 0.33
CACNA1B Q00975 1/20 0.33
CACNB1 Q02641 1/20 0.33
CACNA1C Q13936 1/20 0.33
ACHE P22303 1/20 0.32
CHRM5 P08912 1/20 0.31
ADRA2C P18825 1/20 0.31
SIGMAR1 Q99720 2/20 0.31
SCN1A P35498 1/20 0.31
SCN4A P35499 1/20 0.31
SCN7A Q01118 1/20 0.31
KCNH2 Q12809 1/20 0.31
SCN5A Q14524 1/20 0.31
SCN9A Q15858 1/20 0.31
SCN2A Q99250 1/20 0.31
SCN3A Q9NY46 1/20 0.31
SCN11A Q9UI33 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22565135 0.93 NCF1 (0.42) NCF1OPRM1OPRL1CACNA2D1CACNA1B
SCHEMBL24267159 0.91 NCF1 (0.38) NCF1OPRM1OPRL1CACNA2D1CACNA1B
SCHEMBL22564909 0.89 NCF1 (0.39) NCF1OPRM1OPRL1CACNA2D1CACNA1B
SCHEMBL27290168 0.89 NCF1 (0.39) NCF1OPRM1OPRL1CACNA2D1CACNA1B
SCHEMBL22564903 0.87 OPRM1 (0.42) NCF1OPRM1OPRL1CACNA2D1CACNA1B
SCHEMBL24267030 0.87 NCF1 (0.43) NCF1OPRM1OPRL1CACNA2D1CACNA1B
SCHEMBL26705112 0.86 NCF1 (0.39) NCF1OPRM1OPRL1CACNA2D1CACNA1B
SCHEMBL24267397 0.85 GBA1 (0.36) OPRM1OPRL1CACNA2D1CACNA1BCACNB1
SCHEMBL22565121 0.84 NCF1 (0.41) NCF1OPRM1OPRL1CACNA2D1CACNA1B
SCHEMBL24480578 0.83 NCF1 (0.35) NCF1OPRM1OPRL1CACNA2D1CACNA1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023239629-A1 COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS THAT DEGRADE CDK2 Plexium, Inc. (US) 2023-12-14 WO disclosed
WO-2022047145-A1 RAPIDLY ACCELERATING FIBROSARCOMA PROTEIN DEGRADING COMPOUNDS AND ASSOCIATED METHODS OF USE ARVINAS OPERATIONS, INC. (US) 2022-03-03 WO disclosed